Latest papers

Varicella zoster virus--specific immune response after treatment with sodium stibogluconate for cutaneous leishmaniasis.

Modulation of gene expression in human macrophages treated with the anti-leishmania pentavalent antimonial drug sodium stibogluconate.

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis.

Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.

Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment.

Acute erythroid toxicity in visceral leishmaniasis: a rare complication of antimonial therapy.

IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India.

Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs.

Treatment of mucosal leishmaniasis in Latin America: systematic review.

Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.

Cutaneous leishmaniasis in southern Sri Lanka.

Efficacy of SSG and SSG/IFNalpha2 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG anti-tumor action.

Pharmacovigilance in kala-azar patients with severe thrombocytopenia caused by sodium antimony gluconate miltefosine.

Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy.

Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.

[A case of antimony resistant kala-azar cured with amphotericin B].

Echocardiographic evaluation of cardiac status in Indian visceral leishmaniasis patients.

Milia and cutaneous leishmaniasis.

Circulating immune complexes (IC) and IC-induced levels of GM-CSF are increased in sudanese patients with acute visceral Leishmania donovani infection undergoing sodium stibogluconate treatment: implications for disease pathogenesis.

Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?